
SBJ Pharmaceuticals Private Limited
About SBJ Pharmaceuticals Private Limited
Data last updated:
SBJ Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 September 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U33100DL2020PTC369913. Its GSTIN is 07ABECS4501L1ZB (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Vikas Bakshi and Jitender Kumar Madan.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Fno. 301 T/F Blk B2A Sec 18 B Pkt 2 Dwarka New Delhi, Delhi, India – 110075.
As per the financials filed for FY 2024, the company reported a revenue of ₹28.83 Lakh. For the same year it recorded a net profit of ₹7,806 (net margin 0.3%) and EBITDA of ₹10,548 (EBITDA margin 0.4%).
Court records list 1 case involving the company, including 1 filed against it; 1 case is pending.
Company details
Contact details
SBJ Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressFno. 301 T/F Blk B2A Sec 18 B Pkt 2 Dwarka New Delhi, Delhi, India – 110075
- IndustryPharma, Drug Formulation & Development
To see the full contact details of SBJ Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of SBJ Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of SBJ Pharmaceuticals Private Limited, buy the company report.
Financials of SBJ Pharmaceuticals Private Limited
FY 2025 filings availableSBJ Pharmaceuticals Private Limited reported revenue of ₹28.83 Lakh for FY 2024.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹10,548 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹7,806 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 0.4% | |||
| Net Profit Margin | 0.3% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of SBJ Pharmaceuticals Private Limited, buy the company report.
Board of directors of SBJ Pharmaceuticals Private Limited
SBJ Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vikas Bakshi Also directs: SBJ BPO Services Limited, SBJ Fintech Services Private Limited | Director | 14 Sep 2020 | 6 Years 1 Months | Current |
| Jitender Kumar Madan | Director | 24 Sep 2020 | 6 Years 1 Months | Current |
Peer comparison
SBJ Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Xemda Pharmaceuticals Private Limited | ₹28.89 Lakh (FY 2025) | -10.0% | Uttam Nagar, New Delhi, Delhi, India | |||
| Melden Pharmaceuticals Private Limited | ₹28.86 Lakh (FY 2017) | Bangalore, Karnataka, India | ||||
| SBJ Pharmaceuticals Private Limitedthis company | ₹28.83 Lakh (FY 2024) | ₹7,806 | 0.3% | Delhi, India | ||
| Novotel Pharmaceuticals Private Limited | ₹28.82 Lakh (FY 2025) | 216.0% | Patna, Bihar, India |
To see the full peer comparison of SBJ Pharmaceuticals Private Limited, buy the company report.
Legal cases
SBJ Pharmaceuticals Private Limited has 1 court case on record: 1 filed against it. All case is pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, South East, Delhi | Cheque dishonour complaint | Filed against the company by Packtabs Pharma Pvt Ltd Through Akshat Gupta | Pending |
To see the full case history of SBJ Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for SBJ Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
SBJ Pharmaceuticals Private Limited has 1 active EPFO establishment as of Apr 04, 2024.
GST
SBJ Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07ABECS4501L1ZB | Delhi | Active | 29 Dec 2020 |
To see the full GST registrations and return filing status of SBJ Pharmaceuticals Private Limited, buy the company report.
Recent activity
SBJ Pharmaceuticals Private Limited has 3 board changes on record since 2020: 2 appointments and 1 cessation. The latest: Ravi Bhatia ceased to be Director on 06 Mar 2024.
Frequently asked questions
SBJ Pharmaceuticals is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 14 September 2020 (6+ years old) and is registered under CIN U33100DL2020PTC369913.
SBJ Pharmaceuticals has 2 current directors:
- Vikas Bakshi - Director
- Jitender Kumar Madan - Director
The latest financial statements of SBJ Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of SBJ Pharmaceuticals is 07ABECS4501L1ZB, registered in Delhi.
The CIN (Corporate Identification Number) of SBJ Pharmaceuticals is U33100DL2020PTC369913. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
SBJ Pharmaceuticals has 1 court case on record: 1 filed against it. 1 is pending.
SBJ Pharmaceuticals was incorporated on 14 September 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of SBJ Pharmaceuticals by revenue are Xemda Pharmaceuticals Private Limited, Melden Pharmaceuticals Private Limited, Novotel Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (retail trading).
Ravi Bhatia ceased to be Director on 06 Mar 2024. Jitender Kumar Madan was appointed as Director on 24 Sep 2020. Vikas Bakshi was appointed as Director on 14 Sep 2020.
The registered office of SBJ Pharmaceuticals is at Fno. 301 TF Blk B2A Sec 18 B Pkt 2 Dwarka New Delhi, Delhi, India – 110075.
SBJ Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.